Gilead Sciences Inc.
GILD | NASDAQ
$150.56
+$0.45 (+0.30%)
At close: Sep 21, 2026, 4:00 PM ET
$149
-$1.56 (-1.04%)
After-hours:
Sep 21, 2026, 7:57 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 7.56B | 9.99B | 6.09B | 5.41B | 5.34B | 6B |
Short-Term Investments | 2.05B | 1.58B | 1.18B | 973M | 1.18B | 1.41B |
Long-Term Investments | 2.97B | n/a | 1.16B | 1.25B | 1.31B | 502M |
Other Long-Term Assets | 4.85B | 3.77B | 4.79B | 4.8B | 4.96B | 5.71B |
Receivables | 4.91B | 4.42B | 4.66B | 4.78B | 4.49B | 4.89B |
Inventory | 1.77B | 1.71B | 1.79B | 1.51B | 1.62B | 1.68B |
Other Current Assets | 1.14B | 995M | 2.37B | n/a | n/a | n/a |
Total Current Assets | 18.34B | 19.17B | 16.09B | 14.44B | 14.77B | 16B |
Property-Plant & Equipment | 5.61B | 5.41B | 5.32B | 5.48B | 5.12B | 4.97B |
Goodwill & Intangibles | 25.29B | 28.26B | 34.77B | 37.21B | 41.79B | 41.23B |
Total Long-Term Assets | 40.68B | 39.82B | 46.04B | 48.73B | 53.18B | 52.41B |
Total Assets | 59.02B | 59B | 62.13B | 63.17B | 67.95B | 68.41B |
Account Payables | 715M | 833M | 550M | 905M | 705M | 844M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 2.81B | 1.82B | 1.8B | 2.27B | 1.52B | 2.76B |
Other Current Liabilities | 3.86B | 3.82B | 3.92B | 3.62B | 1.43B | 1.45B |
Total Current Liabilities | 11.81B | 12B | 11.28B | 11.24B | 11.61B | 11.4B |
Long-Term Debt | 22.13B | 24.9B | 23.19B | 22.96B | 25.18B | 28.65B |
Other Long-Term Liabilities | 2.06B | 2.13B | 3.32B | 5.09B | 5.74B | 6.23B |
Total Long-Term Liabilities | 24.59B | 27.75B | 28.1B | 30.72B | 35.28B | 38.79B |
Total Liabilities | 36.41B | 39.75B | 39.38B | 41.96B | 46.89B | 50.19B |
Total Debt | 24.94B | 26.71B | 24.99B | 25.23B | 26.7B | 31.4B |
Book Value | 22.62B | 19.25B | 22.75B | 21.21B | 21.06B | 18.22B |
Book Value Per Share | 18.02 | 15.34 | 18.08 | 16.81 | 16.69 | 14.43 |
Common Stock | 1M | 1M | 1M | 1M | 1M | 1M |
Retained Earnings | 13.73B | 11.5B | 16.3B | 15.69B | 16.32B | 14.38B |
Comprehensive Income | 39M | 132M | 28M | 2M | 83M | -60M |
Shareholders Equity | 22.7B | 19.33B | 22.83B | 21.24B | 21.07B | 18.2B |
Total Investments | 5.02B | 1.58B | 2.34B | 2.22B | 2.49B | 1.91B |
Add to Watchlist
Select watchlists to add or remove GILD